Buy BPC-157 for Laboratory Research

BPC-157 is a synthetic pentadecapeptide comprising 15 amino-acid residues. Its single-letter sequence is GEPPPGKPADDAGLV. The order of those residues is part of the reference identity: peptide length or the abbreviated name alone cannot establish that identity. “Synthetic” describes production of a defined peptide sequence rather than isolation of a complete naturally occurring protein.

Structured identifiers provide independent reconciliation points. PubChem records the reference structure as CID 9941957, with CAS 137525-51-0, molecular formula C62H98N16O22 and molecular weight 1419.5 g/mol. The UNII is 8ED8NXK95P. No dedicated UniProt entry was found in the reviewed search, so an identifier must not be inferred.

These values describe the database reference structure, not the commercial batch. A name, sequence or database match does not document the supplied material. Product specification, batch code and analytical records must be reconciled separately; chromatographic purity and molecular identity are distinct analytical questions.

Chemical-context source: Chang et al. 2014 · PMID 25415472

No single, conclusively established mechanism accounts for the heterogeneous observations reported for BPC-157 across cell, tissue and animal systems. Publications measure endpoint classes that include cellular migration, angiogenesis-related behaviour, VEGFR2-, Akt- and eNOS-related markers, and NO-related vascular responses. These observations define research questions; they do not establish a primary molecular target or one causal pathway shared across tissues and species.

A changed phosphorylation marker alongside altered cell behaviour may show an association within a defined experiment. Inhibitor experiments may support pathway involvement under those conditions. Neither observation alone identifies direct binding, every intermediate step or a universal molecular target. Concentration, timing, controls, matrix and readout remain integral to interpretation.

Hsieh and colleagues examined several systems in 2017, including a CAM assay, cultured human vascular endothelial cells and a preclinical rat model. Their measurements broaden the set of model-specific observations, but combining model types does not close the mechanism question. The 2020 work used isolated rat aorta plus endothelial- and smooth-muscle-cell assays. A vascular ring retains some tissue architecture, yet it cannot establish whole-organism behaviour.

Mechanism-question sources: Hsieh et al. 2017 · PMID 27847966 · Hsieh et al. 2020 · PMID 33051481

This section describes findings in controlled research and makes no statement about use. The records are ordered by model type rather than by implied evidential progression. Cell culture, explants, isolated tissue, animal protocols and review synthesis answer different questions and cannot be pooled into a single quantitative conclusion. This dossier contains no clinical study.

The seven primary records represented here differ substantially in material characterisation, controls, assay architecture and endpoint selection. A shared substance designation is not a basis for treating cellular migration, protein markers, histology, vascular responses and biomechanical measurements as equivalent. Reproducibility assessment requires the design and methods of each original publication.

Timeline sources are linked within the model rows.

“BPC-157” and “BPC 157” designate the same reference peptide sequence. “Body Protection Compound 157” denotes the same reference material, and published work uses the closely related spelling “body protective compound-157”; neither name was confirmed as an official PubChem synonym in the reviewed view, and neither states a function. Confirmed identifiers and sequence provide clearer reconciliation than an expanded name.

A review is a synthesis of earlier publications, not another primary experiment. It can map terminology and model coverage, but a specific claim must still be checked against the relevant primary record. Review breadth does not convert preclinical observations into clinical evidence. Likewise, human-derived endothelial cells studied in vitro remain cultured cells, not a human study.

BPC-157, TB-500 and Wolverine Blend are separate catalogue positions. Wolverine Blend combines BPC-157 and TB-500, but no primary literature for that combination is included in this evidence inventory. Findings for BPC-157 cannot be transferred to TB-500 or the combination, and a shared catalogue context provides no analytical equivalence.

The evidence does not establish direct target binding, a uniform cross-model pathway, human outcomes or properties of a commercial batch. It also does not make different endpoint classes interchangeable. Each statement must retain its model, species, method and measurement boundary.

Review source: Seiwerth et al. 2021 · PMID 34267654

Laboratories that buy BPC-157 for a documented project should reconcile the designation, sequence, CAS, PubChem CID and batch code with the product specification and matching batch documentation. The certificate of analysis should attribute test date, analytical method and result to the relevant batch. A document without a matching batch identifier cannot substantiate the supplied material.

Any purity statement must be batch- and method-specific. HPLC may describe a chromatographic profile or purity result for the tested batch under the reported method; it does not establish a blanket property of BPC-157. HPLC also does not replace suitable mass-spectrometry-supported identity evidence. Purity assessment and molecular assignment answer different analytical questions.

Published research describes model-specific questions and measurements, whereas supply records document the material made available to a laboratory. Neither substitutes for the other. This record makes no assertion about physical presentation, content amount, storage conditions, temperature, stability period or shelf life. Released product specification and matching batch documentation remain decisive.

Research use only. For laboratory research only. Not for human or veterinary use. Not intended to diagnose, treat, cure or prevent any disease. Not a medicinal product, food or cosmetic.